Sol-Gel Technologies Ltd.

SLGL

Healthcare Biotechnology

Sol-Gel Technologies Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $19.4 million, up 68.0% from fiscal 2024.

Revenue
−96.6%
EPS
−127.1%
Free cash flow
−8.76%

Quarter to June 2026, against a year earlier

61.01 2.00 −3.17%
Market cap
$199.8M
P/E
n/m
Fwd P/E
n/m
Dividend yield
—
F-score
6/9
Net debt / EBITDA
3.2×
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — 4 3 4 3 2 3 6
P/E ratio
— 0.00 0.00 0.00 0.00 52.86 0.00 0.00 0.00 0.00
Altman Z-Score
— — 8.08 19.22 11.09 5.31 8.49 (5.24) (6.71) (0.53)
P/S ratio
— 0.00 833.84 14.63 25.20 5.46 28.17 21.27 2.25 6.06
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
— (59.24) 8.18 0.58 (1.74) 0.49 (0.21) (8.79) (14.16) (19.59)
Beneish M-Score
— — — — (3.34) 1.64 (1.34) (5.06) 4.12 (3.60)
P/Operating CF
— (12.22) (12.97) (40.41) (26.66) (20.58) (13.20) (3.99) (1.87) 364.60
P/B ratio
— 0.00 1.68 6.39 4.35 3.07 2.59 0.86 0.90 5.15
EV/Sales
— 0.00 859.75 15.28 29.37 6.85 39.56 45.30 5.84 8.19
EV/EBITDA
— 0.00 0.00 0.00 0.00 72.27 0.00 0.00 0.00 0.00
EV/FCF
— (3.09) (2.72) (5.03) (3.59) (3.90) (4.32) (1.66) (2.25) (7.70)
Current Ratio
0.20 0.16 13.48 8.58 8.95 4.88 12.93 9.10 5.92 4.37
Net Debt/EBITDA
(1.49) (1.94) 1.89 2.01 0.98 (5.67) 1.35 0.97 2.03 3.23
Debt/Equity
(1.19) (1.24) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
96.94% 75.13% (574.54%) (42.29%) (56.70%) 6.05% (30.52%) (67.37%) (31.35%) (23.72%)
ROA
(216.04%) (240.06%) (75.77%) (37.58%) (48.63%) 5.02% (25.77%) (59.27%) (26.08%) (18.63%)
ROIC
0.00% (259.63%) (1,090.04%) (777.13%) (85.60%) 5.48% (48.15%) (171.82%) (152.12%) 0.00%
Return on Tangible Assets
63.84% 58.09% (50.57%) (47.69%) (59.47%) 6.93% (36.95%) (73.46%) (40.36%) (29.26%)
Average Days of Receivables
— 0.00 0.00 65.66 89.60 152.49 744.48 88.55 113.73 37.05
Earnings Yield
— (44.87%) (29.70%) (7.29%) (13.19%) 1.89% (13.65%) (82.79%) (40.86%) (5.29%)
Free Cash Flow Yield
— (52.30%) (37.97%) (20.78%) (32.50%) (32.16%) (32.50%) (128.67%) (115.60%) (17.55%)
Free Cash Flow per Share
(30.02) (41.36) (13.72) (11.82) (11.38) (3.40) (4.17) (6.57) (4.98) 0.12
Book value per Share
(49.82) (83.78) 35.77 26.86 22.52 24.11 18.25 14.27 10.36 8.19
Free Cash Flow
(18.88) (26.01) (24.52) (23.10) (25.69) (7.83) (9.65) (17.79) (13.88) 0.33
EV/EBIT
— 0.00 0.00 0.00 0.00 72.27 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates